Literature DB >> 8474451

Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis.

D L Galson1, J O Hensold, T R Bishop, M Schalling, A D D'Andrea, C Jones, P E Auron, D E Housman.   

Abstract

The hematopoietic-specific DNA-binding protein B1 binds to the DNA consensus sequence AAAGRGGAARYG located twice in intervening sequence 2 of both of the mouse beta-globin genes (D. L. Galson and D.E. Housman, Mol. Cell. Biol. 8:381-392, 1988). B1 was cloned by expression of a murine erythroleukemia (MEL) cell cDNA library in transfected COS cells and screening by electrophoretic mobility shift analysis. B1 is identical to the proto-oncogene Spi-1/PU.1 (Spi-1), an ets family member. Protein-DNA contacts are shown to resemble those of the helix-turn-helix homeodomain proteins. By Northern (RNA) analysis, we found that Spi-1 mRNA is present at low levels during murine CFU-E maturation and is at least 20-fold higher in uninduced MEL, a transformed proerythroblast-like cell line which contains an activating/transforming insertion of spleen focus-forming virus at the Spi-1 locus. Dimethyl sulfoxide-induced MEL cell differentiation decreases Spi-1 mRNA to approximately 20% of the uninduced level before commitment occurs. In addition to erythroid cells, Spi-1 mRNA is present in B cells, myelomonocytes, and mast cells but not in T cells and nonhematopoietic cell types. In situ hybridization demonstrated Spi-1 mRNA expression in bone marrow, spleen, interstitial nonhepatocytes of the liver, and interstitial nontubular cells of the testis. The Spi-1 locus was mapped on human chromosome 11 to the same interval as ACP2 (lysosomal acid phosphatase), between the anonymous DNA markers D11S33 and D11S14. This region has not yet been found to be associated with a human malignancy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474451      PMCID: PMC359686          DOI: 10.1128/mcb.13.5.2929-2941.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  81 in total

1.  Nucleosomes are phased along the mouse beta-major globin gene in erythroid and nonerythroid cells.

Authors:  R Benezra; C R Cantor; R Axel
Journal:  Cell       Date:  1986-03-14       Impact factor: 41.582

2.  DNase I hypersensitive sites of globin genes of uninduced Friend erythroleukemia cells and changes during induction with dimethyl sulfoxide.

Authors:  J M Balcarek; F A McMorris
Journal:  J Biol Chem       Date:  1983-09-10       Impact factor: 5.157

3.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

4.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

5.  Rapid transfer of DNA from agarose gels to nylon membranes.

Authors:  K C Reed; D A Mann
Journal:  Nucleic Acids Res       Date:  1985-10-25       Impact factor: 16.971

6.  Regulation of human interleukin-2 gene: functional DNA sequences in the 5' flanking region for the gene expression in activated T lymphocytes.

Authors:  T Fujita; H Shibuya; T Ohashi; K Yamanishi; T Taniguchi
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

7.  The beta-subunit of follicle-stimulating hormone is deleted in patients with aniridia and Wilms' tumour, allowing a further definition of the WAGR locus.

Authors:  T Glaser; W H Lewis; G A Bruns; P C Watkins; C E Rogler; T B Shows; V E Powers; H F Willard; J M Goguen; K O Simola
Journal:  Nature       Date:  1986 Jun 26-Jul 2       Impact factor: 49.962

8.  Isolation and induction of erythroleukemic cell lines with properties of erythroid progenitor burst-forming cell (BFU-E) and erythroid precursor cell (CFU-E).

Authors:  T Shibuya; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

9.  Localization of the human oncogene SPI1 on chromosome 11, region p11.22.

Authors:  V C Nguyen; D Ray; M S Gross; M F de Tand; J Frézal; F Moreau-Gachelin
Journal:  Hum Genet       Date:  1990-05       Impact factor: 4.132

10.  Regulated expression of human A gamma-, beta-, and hybrid gamma beta-globin genes in transgenic mice: manipulation of the developmental expression patterns.

Authors:  G Kollias; N Wrighton; J Hurst; F Grosveld
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

View more
  53 in total

1.  Do lampreys have lymphocytes? The Spi evidence.

Authors:  S Shintani; J Terzic; A Sato; M Saraga-Babic; C O'hUigin; H Tichy; J Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

2.  Mutants of ETS domain PU.1 and GGAA/T recognition: free energies and kinetics.

Authors:  F Pio; N Assa-Munt; J Yguerabide; R A Maki
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

3.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

4.  Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors.

Authors:  Peter C Hollenhorst; David A Jones; Barbara J Graves
Journal:  Nucleic Acids Res       Date:  2004-10-21       Impact factor: 16.971

5.  The conserved 5'-untranslated leader of Spi-1 (PU.1) mRNA is highly structured and potently inhibits translation in vitro but not in vivo.

Authors:  J O Hensold; C A Stratton; D Barth
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

6.  Reprogramming leukemia cells to terminal differentiation and growth arrest by RNA interference of PU.1.

Authors:  Michael Papetti; Arthur I Skoultchi
Journal:  Mol Cancer Res       Date:  2007-10       Impact factor: 5.852

7.  Transgenic expression of Spi-C impairs B-cell development and function by affecting genes associated with BCR signaling.

Authors:  Xiang Zhu; Brock L Schweitzer; Eric J Romer; Courtney E W Sulentic; Rodney P DeKoter
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

8.  Inhibition of hematopoiesis by competitive binding of transcription factor PU.1.

Authors:  M T Voso; T C Burn; G Wulf; B Lim; G Leone; D G Tenen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

9.  A combined computational and experimental approach reveals the structure of a C/EBPβ-Spi1 interaction required for IL1B gene transcription.

Authors:  Sree H Pulugulla; Riley Workman; Nathan W Rutter; Zhiyong Yang; Juraj Adamik; Brian Lupish; David A Macar; Samir El Abdouni; Emilio Xavier Esposito; Deborah L Galson; Carlos J Camacho; Jeffry D Madura; Philip E Auron
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

10.  Lipopolysaccharide-dependent interaction between PU.1 and c-Jun determines production of lipocalin-type prostaglandin D synthase and prostaglandin D2 in macrophages.

Authors:  Myungsoo Joo; Minjae Kwon; Yong-Jig Cho; Ningning Hu; Tetyana V Pedchenko; Ruxana T Sadikot; Timothy S Blackwell; John W Christman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-30       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.